The Four Phases of a Migraine Attack Explained

Most people think of migraine as a headache. A bad one, certainly, but still just a headache. That framing misses most of what actually happens. A migraine attack is a neurological event that unfolds across four distinct phases, each with its own symptoms, its own biological activity, and its own implications for how the attack is managed.

Not every person with migraine experiences all four phases in every attack. Some skip the aura entirely. Some never notice a clear prodrome. But understanding the full arc of a migraine attack helps explain why the condition is so disruptive, why early treatment matters, and why so many people describe feeling unwell for days even when the headache itself only lasts a few hours.

Phase One: The Prodrome

The prodrome is the earliest phase of a migraine attack. It begins hours before the headache arrives, sometimes as much as twenty-four to forty-eight hours before. The symptoms are subtle enough that many people do not connect them to the migraine until they have been tracking their attacks long enough to see the pattern.

Common prodrome symptoms include excessive yawning, neck stiffness, increased sensitivity to light or sound, food cravings, mood changes, fatigue, and difficulty concentrating. Some people become irritable or anxious. Others feel an unusual sense of energy or euphoria, a phenomenon sometimes described as a false high before the storm.

These symptoms reflect activity in the hypothalamus, a region of the brain involved in regulating sleep, appetite, and mood. Neuroimaging research has documented increased hypothalamic activation during the prodrome phase, providing biological confirmation of what patients report. The prodrome is not a warning sign in a loose metaphorical sense. It is measurable neurological activity that precedes the full attack.

Recognizing the prodrome matters clinically. People who can identify their early warning signs have a longer window to take preventive action, adjust their schedule, or begin acute treatment before the headache fully establishes itself.

Phase Two: The Aura

Aura occurs in roughly thirty percent of people with migraine. It is a series of neurological symptoms that typically develops gradually over five to twenty minutes and resolves within sixty minutes. In most cases, aura precedes the headache phase, though it can occur alongside it or, rarely, without any headache at all.

Visual aura is the most common type. It often begins as a small spot of flickering light near the center of the visual field that gradually expands into an arc of zigzag lines, sometimes described as a crescent of shimmering light or a fortification pattern because of its resemblance to the walls of a medieval fortress. A blind spot, called a scotoma, frequently accompanies the visual disturbance.

Sensory aura is the second most common type. It produces tingling or numbness that typically begins in the hand and spreads up the arm toward the face. Speech aura, which involves difficulty finding words or producing speech, is less common. Motor aura, which involves temporary weakness, is rare and characteristic of a distinct subtype called hemiplegic migraine.

The underlying mechanism of aura is cortical spreading depression, the wave of electrical activity described in detail in the previous article in this series. The specific symptoms depend on which region of the brain the wave traverses.

Phase Three: The Headache

The headache phase is the most recognizable and typically the most disabling part of a migraine attack. It can last anywhere from four hours to seventy-two hours without treatment. The pain is usually moderate to severe, often throbbing or pulsating, and frequently unilateral, though it can affect both sides of the head.

Routine physical activity worsens the pain. Walking up stairs, bending forward, or even shifting position can intensify it noticeably. Nausea is present in the majority of attacks. Vomiting occurs in a significant portion. Sensitivity to light and sound can make ordinary environments feel assaultive.

Some people also experience allodynia during the headache phase, a state in which normally non-painful stimuli become painful. Brushing hair, wearing glasses, or resting a cheek against a pillow can hurt. Allodynia is a marker of central sensitization, a state in which the brain's pain processing centers have become progressively amplified as the attack has developed. Research has shown that treating migraine before allodynia sets in significantly improves the effectiveness of acute medications.

This is one of the most important practical findings in migraine neuroscience. Early treatment, taken at the first sign of the headache rather than once the pain has become severe, produces better outcomes. Waiting to confirm that the headache is a migraine before taking medication is a strategy that works against the biology of the condition.

Phase Four: The Postdrome

The headache ends. The attack does not. The postdrome phase follows the pain and can persist for up to twenty-four hours. It is sometimes called the migraine hangover, and the comparison is apt. People in the postdrome commonly report profound fatigue, cognitive difficulties, trouble concentrating, mood changes, and a general sense of depletion.

Neuroimaging studies have confirmed that brain activity remains altered during the postdrome, providing biological evidence for symptoms that have historically been dismissed as exaggeration or reluctance to return to normal activity. The postdrome is real, it is measurable, and it extends the functional impact of a migraine attack well beyond the headache itself.

For someone with frequent attacks, the postdrome of one attack can overlap with the prodrome of the next. The window of feeling fully well can be narrow.

Why Knowing the Phases Matters

A migraine attack that spans all four phases can affect a person for two to three days. For someone with episodic migraine who experiences four attacks per month, that is a significant portion of their life spent in some stage of a neurological event. For someone with chronic migraine, defined as fifteen or more headache days per month, the phases can blur together in ways that make it difficult to identify where one attack ends and another begins.

Tracking the phases of an attack, not just the headache, gives both patients and their clinicians a more complete picture of the condition's true burden. It also helps identify patterns in the prodrome that can serve as reliable early warning signs, creating opportunities to intervene before the attack reaches its most disabling stage.